Literature DB >> 12110391

In vitro metabolism of a nitroderivative of acetylsalicylic acid (NCX4016) by rat liver: LC and LC-MS studies.

Marina Carini1, Giancarlo Aldini, Marica Orioli, Roberto Maffei Facino.   

Abstract

The metabolism of a nitroderivative of acetylsalicylic acid, benzoic acid, 2-(acetyloxy)-3-[(nitrooxy)methyl]phenyl ester (NCX4016), the lead compound of a new class of NO-releasing non steroidal-antiinflammatory drugs has been studied in vitro in rat liver subcellular fractions (S 9000xg, microsomes, cytosol). Samples were extracted with CH3CN (2 vol.) containing 1% H3PO4 (2 M), vortexed for 3 min and then centrifuged for 5 min at 5000 rpm. Supernatants were diluted with 0.02 M phosphoric acid and analysed by reverse-phase LC. Linearity of calibration for NCX4016 and metabolites was observed over the range 0.25-50 microg/ml with coefficients of determination greater than 0.9996. Extraction efficiency from spiked liver samples ranged from 85 to 95% for all the analytes. In the S 9000xg fraction, NCX4016 undergoes rapid metabolization, with the formation of salicylic acid (SA) and [3-(nitrooxymethyl)phenol] (HBN). HBN is then rapidly metabolised to 3-hydroxybenzylalcohol (HBA), and mainly to a new metabolic species, whose formation takes place specifically in the liver cell cytosol. LC-MS analysis (electrospray ionisation) of the cytosol extract in negative and positive-ion modes furnished deprotonated [M-H]- and protonated [M+H]+ molecular ions at m/z 412 and 414, respectively, accompanied by the typical clusters with sodium. MS/MS analysis in negative-ion mode, by selection and collision of the ion at m/z 412, gave a fragmentation pattern characterized by the ions at m/z 272 and 254, which allowed to assign the structure of 1-(glutathion-S-yl)methylene-3-hydroxy-benzene, a conjugated product between GSH and the benzyl carbon atom of HBN. In rat liver cytosol HBN is completely metabolised to this thioether adduct within 30 min incubation; the process is enzymatically mediated by GSH transferase and strictly dependent on GSH availability. The relevance of this new metabolic pathway in NCX4016 detoxification by rat liver is discussed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12110391     DOI: 10.1016/s0731-7085(02)00147-4

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  8 in total

1.  Nitric oxide and cisplatin resistance: NO easy answers.

Authors:  John J Turchi
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-13       Impact factor: 11.205

2.  Aspirin and low-dose nitric oxide-donating aspirin increase life span in a Lynch syndrome mouse model.

Authors:  Michael A McIlhatton; Jessica Tyler; Laura A Kerepesi; Tina Bocker-Edmonston; Melanie H Kucherlapati; Winfried Edelmann; Raju Kucherlapati; Levy Kopelovich; Richard Fishel
Journal:  Cancer Prev Res (Phila)       Date:  2011-03-24

3.  Pharmacokinetic and pharmacodynamic study of NO-donating aspirin in F344 rats.

Authors:  Chinthalapally V Rao; Stancy Joseph; Li Gao; Jagan M R Patlolla; Chang-In Choi; Levy Kopelovich; Vernon E Steele; Basil Rigas
Journal:  Int J Oncol       Date:  2008-10       Impact factor: 5.650

4.  Degradation of NF-κB, p53 and other regulatory redox-sensitive proteins by thiol-conjugating and -nitrosylating drugs in human tumor cells.

Authors:  Ameya Paranjpe; Kalkunte S Srivenugopal
Journal:  Carcinogenesis       Date:  2013-01-25       Impact factor: 4.944

5.  Reversal to cisplatin sensitivity in recurrent human ovarian cancer cells by NCX-4016, a nitro derivative of aspirin.

Authors:  Anna Bratasz; Nathan M Weir; Narasimham L Parinandi; Jay L Zweier; Rajagopalan Sridhar; Louis J Ignarro; Periannan Kuppusamy
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-23       Impact factor: 11.205

6.  Nitrates and NO-NSAIDs in cancer chemoprevention and therapy: in vitro evidence querying the NO donor functionality.

Authors:  Tareisha Dunlap; Samer O Abdul-Hay; R Esala P Chandrasena; Ghenet K Hagos; Vaishali Sinha; Zhiqiang Wang; Huali Wang; Gregory R J Thatcher
Journal:  Nitric Oxide       Date:  2008-04-23       Impact factor: 4.427

Review 7.  The evolving landscape for cellular nitric oxide and hydrogen sulfide delivery systems: A new era of customized medications.

Authors:  Kearsley M Dillon; Ryan J Carrazzone; John B Matson; Khosrow Kashfi
Journal:  Biochem Pharmacol       Date:  2020-03-26       Impact factor: 5.858

8.  (1S,4S,5S,8R)-8-Nitro-oxy-2,6-dioxa-bicyclo-[3.3.0]octan-4-yl 3,4,5-triacetoxy-benzoate.

Authors:  Yue Zhang; Ping-An Wang; Meng-Yao Zhang; Xiao-Li Sun
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-10-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.